We describe three preterm neonates with bronchopulmonary dysplasia, pulmonary hypertension and ventricular hypertrophy who incurred subendocardial infarctions, as evidenced by electrocardiographic, laboratory or autopsy findings. We propose that cardiac hypertrophy contributed to the risk for subendocardial ischemia and infarction, and suggest diligence for this complication.
Introduction
Myocardial infarction is an uncommon event in neonates and infants. Reported etiologies in these age groups include coronary artery anomaly, coronary thromboembolus, perinatal asphyxia, aortic stenosis, coarctation of the aorta and myocarditis. [1] [2] [3] We describe here three preterm neonates with bronchopulmonary dysplasia (BPD) and pulmonary hypertension who incurred subendocardial infarctions in association with ventricular hypertrophy.
Case Patient 1 was a 960 g female infant born at 26 weeks. Her Apgar scores were 4, 6 and 8. Resuscitation consisted of bag-mask ventilation, endotracheal intubation and surfactant administration. Initial echocardiograms were normal, except for a patent ductus arteriosus (PDA), which was successfully treated with indomethacin. An electrocardiogram obtained on day of life (DOL) 19 demonstrated increased biventricular forces (amplitude of precordial leads >95th percentile for chronological age); however, echocardiographic findings were unremarkable. She remained ventilator dependent at 1 month of life and had radiographic findings consistent with BPD. A tapering course of dexamethasone was begun on DOL 29 and was associated with improved respiratory status. Attempts at discontinuing dexamethasone were unsuccessful, however, and she remained on dexamethasone (0.1 mg kg À1 alternate days) for several months ( Figure 1 ). Biventricular hypertrophy (BVH) and septal hypertrophy, severe enough to impinge upon left ventricular outflow, were noted by echocardiography on DOL 166. This study also revealed a patent foramen ovale with left-to-right shunting, rare diastolic right-to-left shunting and evidence of pulmonary hypertension (large pulmonary artery, abnormal pulmonary valve motion and characteristic spectral Doppler flow signal envelope) with an estimated pulmonary artery pressure of 64/34 mm Hg (near systemic). She was treated over the ensuing weeks with inhaled nitric oxide, prostacyclin and sildenafil. Despite this management, she had progressive deterioration in her respiratory status. She was frequently agitated and required sedation. An electrocardiogram performed on DOL 202 to monitor the ventricular hypertrophy demonstrated ST depression and inversion of the T waves in all anterior chest leads, consistent with subendocardial ischemia (Figure 2 ). At that time, her oxygen saturations were 90%. Troponin I level was markedly elevated at 9.47 ng ml À1 . She clinically deteriorated over the subsequent 2 days, with worsening metabolic and respiratory acidosis and desaturations. Bradycardia ensued and resuscitation efforts were unsuccessful. She expired on DOL 204. Request for post-mortem examination was declined by the family.
Patient 2 was an 869 g female infant born at 27 weeks gestation. The pregnancy was complicated by monoamniotic twin gestation; the other twin was stillborn due to anencephaly. Apgar scores were 1, 5 and 7. Resuscitation consisted of bag-mask ventilation, endotracheal intubation and surfactant administration. Echocardiogram on DOL 2 showed a patent foramen ovale, BVH and PDA. The PDA was surgically ligated on DOL 13. BVH persisted on echocardiogram. She developed radiologic changes consistent with BPD and remained ventilator-dependent. Pulmonary hypertension was identified by qualitative echocardiographic findings on DOL 123 and was treated with inhaled nitric oxide and prostacyclin ( Figure 1 ). Her respiratory status continued to deteriorate and was unimproved by a 7-day trial of dexamethasone.
She required frequent sedation for agitation and desaturation. Her respiratory acidosis progressed, and more frequent desaturations developed. After discussion with the family, support was withdrawn on DOL 145. On autopsy, she was noted to have BPD with extensive fibrosis, pneumonia and pulmonary vascular changes indicative of pulmonary hypertension (Grade B, Rabinovitch et al. 4 ). The heart demonstrated BVH with multifocal microscopic subendocardial healed infarctions of the papillary muscles and both ventricular walls ( Figure 3) .
Patient 3 was a 723 g male infant born by c-section at 28 weeks gestation. The pregnancy was complicated by twin gestation and prolonged rupture of membranes. Resuscitation included intubation and surfactant administration. Apgar scores were 1, 5 and 7. On the first day, he developed a tension pneumothorax requiring chest compressions, endotracheal epinephrine and chest tube placement. Echocardiogram on the second DOL showed a patent foramen ovale, PDA and qualitative evidence of pulmonary hypertension. He developed pulmonary hemorrhage, pulmonary interstitial emphysema and a pneumatocele. Because a PDA persisted despite indomethacin, it was surgically ligated on DOL 26. BPD was treated with dexamethasone and diuretics. Pulmonary hypertension persisted, and was treated with inhaled nitric oxide, sildenafil and diltiazem (Figure 1) . Echocardiogram on DOL 36 showed BVH, right ventricular dilation and continued pulmonary hypertension. Agitation was managed with fentanyl and/or midazolam. His respiratory status continued to deteriorate and, after discussion with the family, support was withdrawn on DOL 61. On autopsy, the pulmonary findings were consistent with BPD, demonstrating areas of atelectasis and fibrosis, and pneumonia. There were also pulmonary vascular changes indicative of pulmonary hypertension (Grade B, Rabinovitch et al.
4
). The heart demonstrated right ventricular hypertrophy and microscopic areas of fibrosis in both ventricles indicative of healed subendocardial infarctions.
Discussion
The subendocardial distribution of the lesions observed in our cases is consistent with the increased vulnerability to ischemia of this region of the myocardium. The subendocardium is perfused only during diastole, yet has a greater oxygen demand compared with the epicardium, due to excessive wall tension. [5] [6] [7] Subendocardial ischemia has been reported in otherwise normal hearts when oxygen delivery is sufficiently compromised (e.g. asphyxia, PDA, severe anemia). None of the three patients had severe anemia as a potential risk factor for subendocardial infarction; the lowest hemoglobin in any case was 9 mg per 100 ml. Subendocardial ischemia can result from increased myocardial oxygen demand. Animal and adult human studies have demonstrated that the increased metabolic requirements of a hypertrophic myocardium can exceed the coronary vasodilator reserve. 8 Indeed, subendocardial infarction has been attributed to severe ventricular hypertrophy in an adult with pulmonary hypertension. 9 Moreover, a report from 1977 describing autopsy findings in preterm infants who died with severe BPD identified areas of myocardial fibrosis, which were predominantly subendocardial 10 and typically in the setting of ventricular hypertrophy. Each of the three cases presented here demonstrated, in addition to respiratory problems compromising cardiac oxygen delivery, significant ventricular hypertrophy. None of the patients had increased ventricular echogenicity or poor cardiac function, suggestive of endocardial fibroelastosis, as a cause of their hypertrophy or ischemia. Taken together, these observations suggest that ventricular hypertrophy contributes to the risk for subendocardial infarction in a subset of preterm infants with severe BPD.
The diagnosis of myocardial infarction can be particularly challenging in neonates and infants. Angina may be difficult to identify, typically manifesting as nonspecific agitation and irritability. Moreover, standard electrocardiographic criteria for the diagnosis of myocardial infarction in children 11 will identify transmural events, but not isolated subendocardial infarctions. Indeed, myocardial infarction was not clinically suspected in the three cases presented here. Although each of the infants had a history of agitation requiring pharmacologic sedation, this situation is common among infants undergoing prolonged mechanical ventilation. In the first case presented here, an electrocardiogram was fortuitously obtained at a time of subendocardial ischemia. It demonstrated the ST segment depression and inverted T waves typical for subendocardial infarction. These observations led to the confirmatory assessment of cardiac enzyme levels. In two of the three cases, the diagnosis of subendocardial infarction was not made until autopsy. Precise timing of these healed infarctions was not possible. In case 3, they could have been related to events (tension pneumothorax or PDA) predating ventricular hypertrophy. However, a survey of autopsies from preterm infants at our institution over the past 7 years identified no other cases (other than acute agonal) of subendocardial infarction, suggesting that subendocardial infarction in the absence of ventricular hypertrophy is unusual.
Contributors to ventricular hypertrophy in preterm neonates with BPD include pulmonary hypertension, 12 systemic hypertension 13 and treatment with dexamethasone. 14 The risk for ventricular hypertrophy in infants with chronic lung disease is sufficiently high that periodic echocardiograms to assess for myocardial thickening is justified. 15 We suggest that surveillance for ventricular hypertrophy in this population will serve to identify patients at risk for subendocardial ischemia. This potential for subendocardial ischemia provides a basis for aggressive management of pulmonary or systemic hypertension in patients with BPD and cardiac hypertrophy. It, moreover, serves as a consideration relevant to the risks of dexamethasone in this patient population. Consideration might also be given to the consequences of endogenous or exogenous catecholamines on the oxygen demand of the hypertrophied heart. Based on our experience with these cases, we suggest diligence for evidence of cardiac ischemia in infants with BPD and ventricular hypertrophy. Unexplained clinical deterioration, decreased oxygen saturation or agitation requiring sedation may serve as indicators for electrocardiography and measurement of cardiac enzymes to assess for cardiac ischemia. In addition to electrocardiographic criteria for transmural infarction, 11 attention should be given to findings associated with subendocardial infarction (ST depression, T wave inversion). A systematic evaluation for subendocardial ischemia in preterm infants with chronic lung disease and ventricular hypertrophy would contribute to understanding the general incidence, etiology and potential management of this complication.
